G01N 33/5064
Endothelial cells
Official title: {Endothelial cells}
G01N33/5064 (Endothelial cells) appears on 206 US grants and 371 published applications in this corpus.
Search patents in G01N- Granted patents
- 206
- Published applications
- 371
- Assignees
- 238
- Inventors
- 808
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 13 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 10 | 1 |
| 2002 | 13 | 21 |
| 2003 | 9 | 20 |
| 2004 | 5 | 23 |
| 2005 | 4 | 17 |
| 2006 | 9 | 17 |
| 2007 | 6 | 30 |
| 2008 | 5 | 9 |
| 2009 | 6 | 15 |
| 2010 | 11 | 23 |
| 2011 | 7 | 12 |
| 2012 | 8 | 11 |
| 2013 | 5 | 14 |
| 2014 | 8 | 11 |
| 2015 | 4 | 11 |
| 2016 | 6 | 16 |
| 2017 | 6 | 12 |
| 2018 | 7 | 13 |
| 2019 | 12 | 9 |
| 2020 | 8 | 19 |
| 2021 | 2 | 13 |
| 2022 | 7 | 15 |
| 2023 | 13 | 12 |
| 2024 | 3 | 17 |
| 2025 | 3 | 5 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Organ models26 May 2026US 12,638,440 B2The Penn State Research Foundation
- Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers19 May 2026US 12,629,418 B2Julius-Maximilians-UniversitäT WüRzburg
- Ex vivo tumor angiogenesis model31 Mar 2026US 12,590,298 B2The Regents of the University of California
- Cellular-based method for determining the potency of defibrotide24 Mar 2026US 12,584,903 B2Gentium S.R.L.
- Coating agent for inducing differentiation of pluripotent stem cells into brain microvascular endothelium-like cells and use thereof24 Mar 2026US 12,584,906 B2Public University Corporation Nagoya City University
- Bioprinted Three-Dimensional Tumor Model17 Sep 2026US 2026/0275299 A1AdministracióN General Comunidad AutóNoma De Euskadi
- Tissue engineered tube using stem cell, and method for producing same20 Aug 2026US 2026/0242745 A1Tohoku University
- Apparatus for observation of biological activity in a sample and a method for quantifying cancer intravasation events in a biological sample18 Jun 2026US 2026/0168986 A1Center for Neuromusculoskeletal Restorative Medicine Limited
- Three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening11 Jun 2026US 2026/0160753 A1Oregon State University
- Method for evaluating anticancer effect and method for predicting effectiveness of cancer immunotherapy23 Apr 2026US 2026/0110681 A1Toppan Printing Co., Ltd.
Most cited
By later US patents
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- High throughput screening assay systems in microscale fluidic devices353US 6,267,858 B1Caliper Technologies Corp. · 2001
- Vascularized perfused microtissue/micro-organ arrays324US 6,197,575 B1Massachusetts Institute of Technology · 2001
- High-throughput screening assay systems in microscale fluidic devices308US 6,429,025 B1Caliper Technologies Corp. · 2002